Status:
UNKNOWN
Effectiveness of a Community-delivered Integrated Malaria Elimination (CIME) Model in Myanmar
Lead Sponsor:
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
Collaborating Sponsors:
National Malaria Control Program, Myanmar
Conditions:
Malaria
Eligibility:
All Genders
Phase:
NA
Brief Summary
In Myanmar, community health workers, known as malaria volunteers, have played a key role in reducing the malaria burden in the malaria control phase, providing essential malaria services in rural are...
Detailed Description
The CIME model integrates interventions for malaria, dengue, tuberculosis, childhood diarrhoea and Rapid Diagnostic Test (RDT)-negative fever. It will involve the recruitment and training of a volunte...
Eligibility Criteria
Inclusion
- Villages in Ayeyarwaddy, Bago and Yangon Regions and Kayah State townships in Myanmar with National Malaria Control Program (NMCP) trained Integrated Community Malaria Volunteers (ICMVs).
Exclusion
- Townships
- A township will be excluded from the study if:
- The township does not have an NMCP provided ICMV network
- The township has ongoing armed conflict
- The township does not have Vector-Borne Diseases Control (VBDC) staff or malaria focal person
- The location of the township is not geographically or politically feasible for staff from the State/Regional capital city to conduct regular supervision visits
- Villages
- After selection of 8 townships (2 townships from each state/region), villages in the townships will be screened against the exclusion criteria. A village will be excluded from the study if:
- The village is too remote and unable to execute the CIME model completely,
- The village has a government public health facility,
- The village has no mobile network coverage
- The village is in the ongoing armed conflict zone , or
- The village has an ICMV program operated by any organizations other than NMCP
- The village has an Annual Parasite Index (API) \>=5
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
6440 Patients enrolled
Trial Details
Trial ID
NCT04695886
Start Date
January 1 2021
End Date
July 1 2021
Last Update
January 5 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.